Oxytocin Effect on Attention Inhibition
Sponsored by University of Electronic Science and Technology of China
About this trial
Last updated 6 years ago
Study ID
UESTC-neuSCAN-45
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18 to 30 Years
Male
Trial Timing
Ended 7 years ago
What is this trial about?
Effects of intranasal oxytocin (24IU) on cognitive control of attention
What are the participation requirements?
Inclusion Criteria
- Male, healthy participants
- Non smokers
Exclusion Criteria
- Previous or current medical, psychiatric, neurological disorder
- Regular medication
- Use of any psychoactive substances in the 24 hours before experiment
- Contra-indications for oxytocin
- Contra-indications for eye-tracking data acquisition